1. Home
  2. BIO vs QBTS Comparison

BIO vs QBTS Comparison

Compare BIO & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • QBTS
  • Stock Information
  • Founded
  • BIO 1952
  • QBTS 1999
  • Country
  • BIO United States
  • QBTS United States
  • Employees
  • BIO N/A
  • QBTS N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • QBTS Retail: Computer Software & Peripheral Equipment
  • Sector
  • BIO Industrials
  • QBTS Technology
  • Exchange
  • BIO Nasdaq
  • QBTS Nasdaq
  • Market Cap
  • BIO 6.0B
  • QBTS 5.0B
  • IPO Year
  • BIO N/A
  • QBTS N/A
  • Fundamental
  • Price
  • BIO $246.53
  • QBTS $18.90
  • Analyst Decision
  • BIO Strong Buy
  • QBTS Strong Buy
  • Analyst Count
  • BIO 4
  • QBTS 7
  • Target Price
  • BIO $324.25
  • QBTS $15.14
  • AVG Volume (30 Days)
  • BIO 314.0K
  • QBTS 44.2M
  • Earning Date
  • BIO 07-31-2025
  • QBTS 08-07-2025
  • Dividend Yield
  • BIO N/A
  • QBTS N/A
  • EPS Growth
  • BIO N/A
  • QBTS N/A
  • EPS
  • BIO N/A
  • QBTS N/A
  • Revenue
  • BIO $2,541,100,000.00
  • QBTS $21,363,000.00
  • Revenue This Year
  • BIO N/A
  • QBTS $181.76
  • Revenue Next Year
  • BIO $3.42
  • QBTS $55.50
  • P/E Ratio
  • BIO N/A
  • QBTS N/A
  • Revenue Growth
  • BIO N/A
  • QBTS 121.61
  • 52 Week Low
  • BIO $211.43
  • QBTS $0.75
  • 52 Week High
  • BIO $387.99
  • QBTS $19.77
  • Technical
  • Relative Strength Index (RSI)
  • BIO 52.25
  • QBTS 65.36
  • Support Level
  • BIO $244.45
  • QBTS $14.76
  • Resistance Level
  • BIO $264.68
  • QBTS $19.53
  • Average True Range (ATR)
  • BIO 6.91
  • QBTS 1.20
  • MACD
  • BIO -0.61
  • QBTS 0.28
  • Stochastic Oscillator
  • BIO 30.57
  • QBTS 88.95

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

Share on Social Networks: